Non-stackable molecules assemble into porous crystals displaying concerted cavity-changing motions

por Kang, Taewon, Kim, Hongsik, Jeoung, Sungeun, Moon, Dohyun, Moon, Hoi Ri, Lee, Dongwhan
Publicado 2021

Sequential spinal and intracranial dural metastases in gastric adenocarcinoma: A case report

por Kim, Hongsik, Yi, Kyung Sik, Kim, Won-Dong, Son, Seung-Myoung, Yang, Yaewon, Kwon, Jihyun, Han, Hye Sook
Publicado 2018

EGFR Mutation–Positive Unresectable Stage III Non-Squamous Lung Cancer Is Associated with a High Incidence of Brain Metastasis

por Kim, Hongsik, Park, Sehhoon, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju
Publicado 2023

Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitors

por Kim, Hongsik, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Sun, Jong-Mu
Publicado 2021

Expression of PD-L1 as a predictive marker of sensitivity to immune checkpoint inhibitors in patients with advanced biliary tract cancer

por Kim, Hongsik, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Ha, Sang Yun, Park, Joon Oh, Kim, Seung Tae
Publicado 2022

Pembrolizumab-induced psoriatic arthritis treated with disease-modifying anti-rheumatic drugs in a patient with gastric cancer: A case report

por Kim, Sehan, Sun, Jong Hee, Kim, Hongsik, Kim, Hee Kyung, Yang, Yaewon, Lee, Jun Su, Choi, In Ah, Han, Hye Sook
Publicado 2023

Long-term Survival in Non–Small Cell Lung Cancer Patients with Metachronous Brain-Only Oligorecurrence Who Underwent Definitive Treatment

por Kim, Hongsik, Park, Sehhoon, Jung, Hyun Ae, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju
Publicado 2022

Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer

por Lee, Yong-Pyo, Lee, Min-Sang, Kim, HongSik, Kim, Ji-Yeon, Ahn, Jin Seok, Im, Young-Hyuck, Park, Yeon Hee
Publicado 2022

When to apply immune checkpoint inhibitor in patients with refractory advanced gastric cancer

por Kim, Hongsik, Kim, Hana, Lee, Minsang, Kwon, Minsuk, Hong, Jung Yong, Lee, Jeeyun, Lim, Ho Yeong, Kang, Won Ki, Kim, Seung Tae
Publicado 2021

A prospective phase-II trial of biweekly docetaxel plus androgen deprivation therapy in patients with previously-untreated metastatic castration-naïve prostate cancer

por Byeon, Seonggyu, Kim, Hongsik, Jeon, Hwang Gyun, Seo, Seong Il, Jeon, Seong Soo, Lee, Hyun Moo, Lee, Soon Il, Park, Se Hoon
Publicado 2021

Tumor Mutational Burden as a Biomarker for Advanced Biliary Tract Cancer

por Kim, Hongsik, Kim, Hana, Kim, Ryul, Jo, Hyunji, Kim, Hye Ryeon, Hong, Joohyun, Park, Joon Oh, Park, Young Suk, Kim, Seung Tae
Publicado 2021

The Impact of Tumor Mutation Burden on the Effect of Frontline Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Advanced Gastric Cancers

por Kim, Hye Ryeon, Ahn, Soomin, Jo, Hyunji, Kim, Hongsik, Hong, Joohyun, Lee, Jeeyun, Lim, Ho-Yeong, Kang, Won Ki, Kim, Seung Tae
Publicado 2021

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer

por Kim, Hongsik, Kim, Ryul, Kim, Hye Ryeon, Jo, Hyunji, Kim, Hana, Ha, Sang Yun, Park, Joon Oh, Park, Young Suk, Kim, Seung Tae
Publicado 2022

Osimertinib Combined with Systemic Chemotherapy for EGFR Mutant, T790M-Negative, Non–Small Cell Lung Cancer Patients Who Develop Leptomeningeal Metastases with Extracranial Progres...

por Kim, Hye Ryeon, Jo, Hyunji, Kim, Hongsik, Hong, Joohyun, Park, Sehhoon, Jung, Hyun Ae, Lee, Se-Hoon, Ahn, Jin-Seok, Ahn, Myung-Ju
Publicado 2023

Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions

por Kim, Hongsik, Son, Seung-Myoung, Woo, Chang Gok, Lee, Ok-Jun, Kim, Dae Hoon, Yun, Hyo Yung, Yun, Jieun, Kim, Hee Kyung, Yang, Yaewon, Han, Hye Sook
Publicado 2019

Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder

por Kim, Hongsik, Jeong, Byong Chang, Hong, Joohyun, Kwon, Ghee Young, Kim, Chan Kyo, Park, Won, Pyo, Hongryull, Song, Wan, Sung, Hyun Hwan, Hong, Jung Yong, Park, Se Hoon
Publicado 2023

The prevalence of homologous recombination deficiency (HRD) in various solid tumors and the role of HRD as a single biomarker to immune checkpoint inhibitors

por Kim, Hana, Ahn, Soomin, Kim, Hongsik, Hong, Jung Yong, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Kim, Kyoung-Mee, Kim, Seung Tae
Publicado 2021

Long‐term outcomes in patients with advanced and/or metastatic non–small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after...

por Kim, Hongsik, Kim, Dong‐Wan, Kim, Miso, Lee, Youngjoo, Ahn, Hee Kyung, Cho, Jang Ho, Kim, Il Hwan, Lee, Yun‐Gyoo, Shin, Seong‐Hoon, Park, Song Ee, Jung, Jiyoon, Kang, Eun Joo, Ahn, Myung‐Ju
Publicado 2021

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach

por Kim, Hana, Kim, Hyo Jung, Kim, Hongsik, Kim, Hye Ryeon, Jo, Hyunji, Hong, Joohyun, Kim, Ryul, Kim, Ji-Yeon, Ahn, Jin Seok, Im, Young-Hyuck, Lee, Se Kyung, Kim, Haeyoung, Shin, Soo-Yong, Park, Yeon Hee
Publicado 2021

Distinct tumor immune microenvironments in primary and metastatic lesions in gastric cancer patients

por Son, Seung-Myoung, Woo, Chang Gok, Kim, Dae Hoon, Yun, Hyo Yung, Kim, Hongsik, Kim, Hee Kyung, Yang, Yaewon, Kwon, Jihyun, Kwon, Minsuk, Kim, Tae-Yong, Kim, Hyung-Don, Koh, June-Young, Park, Su-Hyung, Shin, Eui-Cheol, Han, Hye Sook
Publicado 2020